Yaning Zhang, MD Surgery Medicare: Medicare Enrolled Practice Location: 2232 Wilborn Ave Ste C, South Boston, VA 24592 Phone: 434-517-3100 |
William Allen Fuller Jr., MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2212 Wilborn Ave, South Boston, VA 24592 Phone: 434-572-8921 Fax: 434-572-2063 |
Gurnam S Bajwa, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2206a Wilborn Ave, South Boston, VA 24592 Phone: 434-572-2744 Fax: 434-572-2785 |
Nicole F Yeshtokin, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 22232 Wilborn Ave Ste C, South Boston, VA 24592 Phone: 434-517-3910 Fax: 434-517-3912 |
Lovetta Pugh, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2232 Wilborn Ave, South Boston, VA 24592 Phone: 434-572-8921 Fax: 434-572-2063 |
Edward Sanford Purvis Ii, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 2232 Wilborn Avenue, Physicians Pavilion, South Boston, VA 24592 Phone: 434-517-0233 |
News Archive
The U.S. Food and Drug Administration today is warning patients and doctors, who use at-home or in-the-office medical devices to monitor levels of the blood thinner, warfarin, that certain test strips used with the devices may provide inaccurate results and should not be relied upon to adjust the drug dosage.
Pediatricians treating a child who has strep throat should reconsider the role of penicillin given that a newer class of antibiotics called cephalosporins are three times more effective, according to a study being published in the April issue of Pediatrics. The findings will spark widespread debate, because they contradict long-established guidelines from the American Academy of Pediatrics, American Heart Association,and World Health Organization.
A new study has shown that at least 400,000 cases of adults with depression in the US could have been avoided if greater measures were in place to discourage teenage use of cannabis. The results of this new study were published this week in the latest issue of the journal JAMA Psychiatry.
A new subcutaneous formulation of RoActemra® (tocilizumab) has today been launched providing thousands of UK rheumatoid arthritis (RA) patients with a potentially life-changing treatment option.1
› Verified 8 days ago